Last 17 quarters of trend data
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q4 '25 | Q3 '25 | Q2 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q4 '23 | Q2 '23 | Q4 '22 | Q2 '22 | Q4 '21 | Q2 '21 | Q4 '20 | Q2 '20 | Q4 '19 | Q4 '18 | Q2 '18 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | -0.08 | — | — | — | — | — | — | 0.12 | — | — | — | — | — | 1.58 | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| P/S Ratio | — | — | — | — | — | — | — | — | 0.60 | 0.64 | 2.32 | 14.78 | 42.93 | 35.96 | 86.74 | 389.58 | 276.22 | — |
| — | — | — | — | — | — | — | — | -98.6% | -98.2% | -97.3% | -96.2% | -84.5% | — | — | — | — | — | |
| P/B Ratio | 0.01 | 0.06 | 0.11 | 0.05 | 0.15 | — | 0.18 | 0.08 | 0.08 | 0.25 | 0.31 | 3.05 | 4.14 | 2.20 | 6.48 | 30.99 | 12.94 | — |
| — | — | -37.4% | -42.9% | +83.8% | — | -43.2% | -97.3% | -98.0% | -88.6% | -95.2% | -90.1% | -68.0% | — | — | — | — | — | |
| P/FCF | — | — | — | — | 4.91 | — | — | — | — | — | — | — | — | — | — | 0.08 | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBITDA | — | — | — | — | 3.84 | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBIT | — | — | — | — | 3.84 | — | — | 0.30 | — | — | — | — | — | 1.70 | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q4 '25 | Q3 '25 | Q2 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q4 '23 | Q2 '23 | Q4 '22 | Q2 '22 | Q4 '21 | Q2 '21 | Q4 '20 | Q2 '20 | Q4 '19 | Q4 '18 | Q2 '18 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | — | — | — | — | — | — | — | — | -154.2% | -70.5% | -110.9% | -57.7% | -92.4% | -107.3% | -248.1% | -483.5% | 17.1% | 14.7% |
| — | — | — | — | — | — | — | — | -66.9% | +34.3% | +55.3% | +88.1% | -641.1% | -831.7% | — | — | — | — | |
| Operating Margin | — | — | — | — | — | — | — | — | -1515.8% | -1178.8% | -1602.4% | -1074.5% | -1488.6% | -1986.5% | -2532.7% | -3382.2% | -2693.4% | -18285.8% |
| — | — | — | — | — | — | — | — | -1.8% | +40.7% | +36.7% | +68.2% | +44.7% | +89.1% | — | — | — | — | |
| Net Margin | — | — | — | — | — | — | — | — | -1272.0% | -1029.9% | -357.4% | -991.9% | -2521.4% | 2271.5% | -1896.0% | -3249.4% | -3868.0% | -20585.1% |
| — | — | — | — | — | — | — | — | +49.6% | -145.3% | +81.2% | +69.5% | +34.8% | +111.0% | — | — | — | — |
| Metric | TTM | Q4 '25 | Q3 '25 | Q2 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q4 '23 | Q2 '23 | Q4 '22 | Q2 '22 | Q4 '21 | Q2 '21 | Q4 '20 | Q2 '20 | Q4 '19 | Q4 '18 | Q2 '18 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -10.7% | -2.3% | -4.6% | -3.5% | -7.8% | — | -18.5% | 18.9% | -53.2% | -67.4% | -12.0% | -40.8% | -49.8% | 47.7% | -38.3% | -40.3% | -51.8% | -22.4% |
| — | — | +75.4% | -118.3% | +85.3% | — | -53.7% | +146.4% | -7.0% | -241.4% | +68.6% | -1.1% | +3.9% | +313.0% | — | — | — | — | |
| ROA | -7.8% | -1.7% | -3.4% | -2.6% | -5.7% | — | -13.8% | 15.2% | -31.1% | -35.3% | -7.8% | -33.4% | -42.3% | 39.3% | -26.3% | -27.8% | -34.3% | -13.2% |
| — | — | +75.0% | -117.0% | +81.7% | — | -75.7% | +145.4% | +26.5% | -189.7% | +70.1% | -20.3% | -23.5% | +396.9% | — | — | — | — | |
| ROIC | -9.7% | — | — | -2.1% | — | -40.0% | -13.2% | -20.1% | -38.1% | -48.7% | — | -82.9% | -32.3% | -33.1% | -37.9% | -31.8% | -23.9% | -10.9% |
| — | — | — | +89.5% | — | +17.8% | — | +75.8% | -17.9% | -47.2% | — | -161.0% | -34.9% | -204.6% | — | — | — | — |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q4 '25 | Q3 '25 | Q2 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q4 '23 | Q2 '23 | Q4 '22 | Q2 '22 | Q4 '21 | Q2 '21 | Q4 '20 | Q2 '20 | Q4 '19 | Q4 '18 | Q2 '18 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.25 | 0.25 | 0.26 | 0.25 | 0.28 | — | 0.26 | 0.23 | 0.04 | 0.88 | 0.23 | 0.01 | 0.06 | 0.03 | 0.18 | 0.44 | 0.31 | 0.65 |
| — | — | +1.5% | +11.6% | +622.1% | — | +13.8% | +1727.6% | -33.6% | +2427.9% | +24.4% | -97.2% | -81.1% | -94.7% | — | — | — | — | |
| Debt / EBITDA | — | — | — | — | 12.16 | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Current Ratio | 0.78 | 0.78 | 0.56 | 2.98 | 0.22 | — | 1.17 | 1.18 | 1.32 | 0.57 | 1.14 | 2.90 | 5.40 | 8.70 | 1.99 | 3.00 | 2.36 | 1.57 |
| — | — | -51.8% | +152.9% | -83.3% | — | +2.5% | -59.3% | -75.5% | -93.5% | -42.9% | -3.5% | +129.0% | +453.7% | — | — | — | — | |
| Quick Ratio | 0.78 | 0.78 | 0.56 | 2.98 | 0.22 | — | 1.17 | 1.18 | 1.24 | 0.56 | 1.13 | 2.89 | 5.39 | 8.69 | 1.98 | 2.99 | 2.35 | 1.57 |
| — | — | -51.8% | +152.9% | -82.2% | — | +2.9% | -59.2% | -77.0% | -93.5% | -42.7% | -3.3% | +128.9% | +453.1% | — | — | — | — | |
| Interest Coverage | -18.99 | — | -21.87 | -8.66 | — | -16.90 | -37.83 | 82.63 | -69.65 | -2794.66 | — | — | -134.62 | 0.00 | -4.32 | -0.00 | -4.15 | -9.38 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 17 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying NIKI stock.
Niki BioSolutions, Inc.'s current P/E is -0.1x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Niki BioSolutions, Inc.'s business trajectory between earnings reports.